TrialBritish journal of clinical pharmacology2007

Single and multiple ascending dose studies of a novel tissue-selective oestrogen receptor modulator, CHF 4227, in healthy postmenopausal women.

Maurizio Civelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.